Results 21 to 30 of about 11,690 (201)

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Antonio Brucato, Michelle Z. Lim‐Watson, Allan Klein, Massimo Imazio, David Cella, Paul Cremer, Martin M. LeWinter, Sushil Allen Luis, David Lin, Dor Lotan, Massimo Pancrazi, Lucia Trotta, Brittany Klooster, Leighann Litcher‐Kelly, Liangxing Zou, Matt Magestro, Alistair Wheeler, John F. Paolini   +17 more
doaj   +1 more source

Una presentación atípica y grave de síndrome poliglandular autoinmune tipo 2

Galicia Clínica, 2022
Background: Recurrent pericarditis has been described as an unusual manifestation of autoimmune polyglandular syndrome type 2 (APS 2). Case report: We describe a case of a 44-year-old woman who was admitted to hospital due to 5 pericarditis, 3 of them ...
Andrea Riaño Pérez, Carles García Cervera, Jorge Peris García, Vicente Giner Galvañ   +3 more
doaj   +1 more source

Acute recurrent pericarditis in thyrotoxicosis

IHJ Cardiovascular Case Reports, 2020
The etiology of acute pericarditis is often thought to be autoimmune, and Graves’ disease has been reported in a few series to manifest as acute pericarditis.
Parvaiz Ahmad Zargar, Sheikh Mohamad Tahir, Hayat Bhat   +2 more
doaj   +1 more source

Colchicine for steroid-resistant recurrent pericarditis in a child [PDF]

Yeungnam University Journal of Medicine, 2018
Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient’s quality of life. Although a treatment strategy in pediatric recurrent pericarditis has
Ju Hee Shin, Dong Hyun Lee, Hee Joung Choi   +2 more
doaj   +1 more source

Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis [PDF]

JACC: Advances
Aqieda Bayat, MD, Ankit Agrawal, MD, Ashwin Kumar, MD, Muhammad Majid, MD, Beni Verma, MD, Abdullah Yesilyaprak, MD, Allan L. Klein, MD   +6 more
doaj   +2 more sources

Colchicine in Treatment of Intractable Postpericardiotomy Syndrome in an Elderly Patient

International Journal of Gerontology, 2011
Postpericardiotomy syndrome is a specific type of acute pericarditis because of a delayed pericardial and/or pleural reaction after thoracic surgery. Relapse after aspirin, nonsteroidal anti-inflammatory drug, and/or steroid treatment or intractable to ...
Lin-Shong Li, Chun-Fu Chen, Der-Yan Tai
doaj   +1 more source

Recurrent pericarditis: an update on diagnosis and management

, 2021
Recurrent pericarditis is a true challenge for clinicians, especially when the patient becomes unresponsive or not tolerant to conventional treatments.
Brucato, Antonio, Andreis, Alessandro, Imazio, Massimo, Casula, Matteo, Avondo, Stefano   +4 more
core   +1 more source

Acute and recurrent pericarditis [PDF]

Vnitřní lékařství, 2019
Pericardial diseases have been until recently relatively neglected entity; however, there has been a markedly increased interest in these disorders in the last decade due to new diagnostic as well as therapeutic options. Various clinical manifestations of pericardial diseases may be generally grouped into pericardial syndromes including pericarditis ...
openaire   +2 more sources

An update on the pathophysiology of acute and recurrent pericarditis

, 2021
a B S T r a c T INTRODUCTION: Pericarditis is an inflammatory disease of the pericardium. Progress has been done in recent years in the understanding of its pathophysiology.
Abbate A., Imazio M., Mauro A. G., Bonaventura A., Brucato A. L., Vecchie A.   +5 more
core   +2 more sources

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

BMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger, Angelos G. Rigopoulos, Peter Schlattmann, Marios Matiakis, Daniel Sedding, Paul Christian Schulze, Michel Noutsias   +6 more
doaj   +1 more source